RSS-Feed abonnieren
DOI: 10.1055/s-0040-1710642
Targeting Wnt11 and collagen-depositing macrophages to reduce fibrosis around implants
Introduction Fibrosis is a common outcome following surgical implantation of biomedical devices, which are a mainstay of modern medicine. Implants elicit a foreign body response resulting in collagen-deposition and fibrotic encapsulation but a better understanding of the pathophysiology is required for new therapeutics to be developed to optimize patient outcome.
Methods Using a murine model to simulate the generation of capsular fibrosis (CF) around implants, we compared its development within Wnt11 KO mice to that of regular Bl/6 mice by placing miniature silicone implants subcutaneously. Cells from the capsules were characterized by FACS, single cell qPCR and RNA sequencing to determine the genetic profiles of those most responsible for fibrotic development. Further, SEM, TEM, 3D-confocal imaging and several stains.
Results We found a significant decrease in fibrotic deposition in the capsules of our Wnt11 KO mice. Additionally, we found the predominant cells across different time-points were myeloid cells and not fibroblasts. We confirmed that these cells were macrophages able to produce ECM by subjecting them to FACS analysis. We found over 80 % of the macrophages expressing collagen1.
Conclusion Our findings exhibit that Wnt signaling&Wnt11 are essential to the progression of CF and suggest that Wnt11 inhibition can be applicable to therapeutics going forward. Additionally, we found a majority of macrophages expressing collagen1, denoting their impact as key mediators within fibrotic capsules as collagen-depositing macrophages. Our findings have widespread clinical implications for the treatment of fibrosis and allow us to develop solutions to therapeutically treat fibrosis.
#
https://www.abstractserver.com/seno2020/uploads/19-COI-1577531943.pdf
Publikationsverlauf
Artikel online veröffentlicht:
24. Juni 2020
© Georg Thieme Verlag KG
Stuttgart · New York